UA61973C2 - Substituted 1,2,3,4,5,6-hexahydro-2.6-methano-3-benzazocine-10-oles, a method for producing the same and the use thereof as medicaments - Google Patents

Substituted 1,2,3,4,5,6-hexahydro-2.6-methano-3-benzazocine-10-oles, a method for producing the same and the use thereof as medicaments Download PDF

Info

Publication number
UA61973C2
UA61973C2 UA2000042088A UA2000042088A UA61973C2 UA 61973 C2 UA61973 C2 UA 61973C2 UA 2000042088 A UA2000042088 A UA 2000042088A UA 2000042088 A UA2000042088 A UA 2000042088A UA 61973 C2 UA61973 C2 UA 61973C2
Authority
UA
Ukraine
Prior art keywords
methyl
benzomorphan
hydroxy
acid
trimethyl
Prior art date
Application number
UA2000042088A
Other languages
English (en)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UA61973C2 publication Critical patent/UA61973C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
UA2000042088A 1997-09-12 1998-09-09 Substituted 1,2,3,4,5,6-hexahydro-2.6-methano-3-benzazocine-10-oles, a method for producing the same and the use thereof as medicaments UA61973C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19740110A DE19740110A1 (de) 1997-09-12 1997-09-12 Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1998/005734 WO1999014199A1 (de) 1997-09-12 1998-09-09 Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
UA61973C2 true UA61973C2 (en) 2003-12-15

Family

ID=7842134

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000042088A UA61973C2 (en) 1997-09-12 1998-09-09 Substituted 1,2,3,4,5,6-hexahydro-2.6-methano-3-benzazocine-10-oles, a method for producing the same and the use thereof as medicaments

Country Status (38)

Country Link
US (1) US6455538B1 (pt)
EP (1) EP1015433B1 (pt)
JP (1) JP3827528B2 (pt)
KR (1) KR100601008B1 (pt)
CN (1) CN1166640C (pt)
AR (1) AR017095A1 (pt)
AT (1) ATE267811T1 (pt)
AU (1) AU751036B2 (pt)
BG (1) BG64418B1 (pt)
BR (1) BR9812443A (pt)
CA (1) CA2302347C (pt)
CO (1) CO5011117A1 (pt)
CZ (1) CZ296909B6 (pt)
DE (2) DE19740110A1 (pt)
DK (1) DK1015433T3 (pt)
EE (1) EE04398B1 (pt)
ES (1) ES2222612T3 (pt)
HR (1) HRP980502B1 (pt)
HU (1) HUP0004588A3 (pt)
ID (1) ID24173A (pt)
IL (1) IL134572A (pt)
MY (1) MY120550A (pt)
NO (1) NO315650B1 (pt)
NZ (1) NZ503710A (pt)
PE (1) PE122899A1 (pt)
PL (1) PL198486B1 (pt)
PT (1) PT1015433E (pt)
RS (1) RS49888B (pt)
RU (1) RU2218334C2 (pt)
SA (1) SA98190765B1 (pt)
SK (1) SK284670B6 (pt)
TR (1) TR200000697T2 (pt)
TW (1) TW505645B (pt)
UA (1) UA61973C2 (pt)
UY (2) UY25175A1 (pt)
WO (1) WO1999014199A1 (pt)
YU (1) YU12000A (pt)
ZA (1) ZA988285B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826365A1 (de) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Verwendung von Benzomorphanderivaten als Analgetikum
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
DE19957156A1 (de) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6683089B2 (en) 2002-02-02 2004-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols
DE10204276A1 (de) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
DE10223783A1 (de) * 2002-05-29 2003-12-11 Boehringer Ingelheim Pharma Neue Formulierung zur parenteralen Applikation eines Na-Kanal-Blockers
US6828311B2 (en) 2002-05-29 2004-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Formulation for the parenteral application of a sodium channel blocker
US20030235576A1 (en) * 2002-06-15 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations for the treatment of ischaemic conditions
DE10226814A1 (de) * 2002-06-15 2004-01-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung ischämischer Zustände
RS54522B1 (en) 2005-12-22 2016-06-30 Newron Pharmaceuticals S.P.A. 2-Phenylethylamino Derivatives as Modulators of Calcium and (or Sodium) Channels
CN101687773B (zh) 2007-06-15 2014-07-30 纽朗制药有限公司 取代的2-[2-(苯基)乙氨基]烷酰胺衍生物及其作为钠和/或钙通道调节剂的应用
EA022973B1 (ru) 2011-06-27 2016-03-31 Ньюрон Фармасьютикалс С.П.А. Фторированные арилалкиламинокарбоксамидные производные

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
US4208523A (en) 1978-11-30 1980-06-17 Sterling Drug Inc. 11-Lower-alkyl-, 11-phenyl-lower-alkyl- and 11-cyclo-lower-alkyl-lower-alkyl-hexahydro-2,6-methano-3-benzazocines
DE4121821A1 (de) * 1991-07-02 1993-01-14 Boehringer Ingelheim Kg Neue benzomorphane und ihre verwendung als arzneimittel
US5607941A (en) * 1992-06-26 1997-03-04 Boehringer Ingelheim Kg Useful for treating neurodegenerative diseases
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan

Also Published As

Publication number Publication date
CZ296909B6 (cs) 2006-07-12
SA98190765B1 (ar) 2006-06-10
CO5011117A1 (es) 2001-02-28
BG104232A (en) 2000-10-31
AR017095A1 (es) 2001-08-22
KR100601008B1 (ko) 2006-07-19
DE59811477D1 (de) 2004-07-01
YU12000A (sh) 2002-11-15
DK1015433T3 (da) 2004-09-27
RU2218334C2 (ru) 2003-12-10
NZ503710A (en) 2002-04-26
PL198486B1 (pl) 2008-06-30
PL339061A1 (en) 2000-12-04
US6455538B1 (en) 2002-09-24
EP1015433A1 (de) 2000-07-05
HRP980502B1 (en) 2005-02-28
NO20001288D0 (no) 2000-03-10
HUP0004588A2 (hu) 2001-07-30
SK284670B6 (sk) 2005-08-04
EP1015433B1 (de) 2004-05-26
JP3827528B2 (ja) 2006-09-27
AU9624298A (en) 1999-04-05
BR9812443A (pt) 2000-09-26
ZA988285B (en) 1999-03-12
NO20001288L (no) 2000-03-13
BG64418B1 (bg) 2005-01-31
TR200000697T2 (tr) 2001-01-22
UY25175A1 (es) 2000-12-29
IL134572A0 (en) 2001-04-30
HUP0004588A3 (en) 2002-10-28
CA2302347C (en) 2008-06-17
JP2001516747A (ja) 2001-10-02
SK3342000A3 (en) 2000-09-12
RS49888B (sr) 2008-08-07
PE122899A1 (es) 1999-12-06
TW505645B (en) 2002-10-11
ES2222612T3 (es) 2005-02-01
NO315650B1 (no) 2003-10-06
ATE267811T1 (de) 2004-06-15
MY120550A (en) 2005-11-30
CN1166640C (zh) 2004-09-15
AU751036B2 (en) 2002-08-08
DE19740110A1 (de) 1999-03-18
UY25439A1 (es) 1999-11-17
PT1015433E (pt) 2004-08-31
ID24173A (id) 2000-07-13
WO1999014199A1 (de) 1999-03-25
CN1269790A (zh) 2000-10-11
HRP980502A2 (en) 1999-06-30
KR20010023879A (ko) 2001-03-26
EE04398B1 (et) 2004-12-15
EE200000129A (et) 2001-02-15
CZ2000894A3 (cs) 2000-09-13
CA2302347A1 (en) 1999-03-25
IL134572A (en) 2005-05-17

Similar Documents

Publication Publication Date Title
US5300517A (en) Piperidine compounds having anti-acetylcholinesterase activity
UA61973C2 (en) Substituted 1,2,3,4,5,6-hexahydro-2.6-methano-3-benzazocine-10-oles, a method for producing the same and the use thereof as medicaments
DD143607A5 (de) Verfahren zur herstellung neuer carbazolyl-(4)-oxy-propanolamin-derivate
JP2003515588A (ja) アルフェンタニル、スフェンタニルおよびレミフェンタニルの新合成法
US4774249A (en) Pyrimidine derivatives for treating malaria
US5240934A (en) Quinoline derivatives
NZ250580A (en) 3-(hetero)aryloxymorphinan derivatives and their use in the manufacture of medicaments
EP0266102B1 (en) Quinoxalinone derivatives
US3948896A (en) N-mono(alkoxymethyl) phenobarbitals, process therefor and therapeutic composition and method containing same
WO1990001025A1 (en) Enamine quaternary compounds, methods of making and their use as muscle relaxants
WO1988001270A1 (en) Pyridopyrimidinediones
AU2003292322A1 (en) Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same
JPH06102657B2 (ja) 新規ベンゾチオピラニルアミン
TW200303197A (en) Chemokine receptor antagonists and methods of use therefor
BG65564B1 (bg) Фенил- и пиридил-тетрахидропиридини, притежаващи tnf-инхибираща активност, метод и междинни съединения за получаването им, фармацевтичен състав, който ги съдържа, и използването им
US3743735A (en) Pharmaceutical compositions containing tropanol esters of alpha-phenyl-alpha-cyclopentyl-acetic acid and methods of use
US3313822A (en) Diphenyl substituted aminoalkyl pyridines
US6245777B1 (en) N-(5-phenyl-tetrahydrofuranyl)methyl- and N-(6-phenyl-tetrahydropyranyl)methyl-substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols
UA68388C2 (en) Substituted indole derivatives, pharmaceutical composition and method of synthesis (variants)
JP2003519687A (ja) 置換1,2,3,4,5,6−ヘキサヒドロ−2,6−メタノ−3−ベンゾアゾシン及び医薬組成物としてのそれらの使用
GB2065113A (en) Ergoline derivatives, their production and pharmaceutical compositions containing them
NO et al. 3rd Phase, Bangalore 560078 (IN).
MXPA01008507A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments
JPS6250463B2 (pt)
CS224245B1 (cs) Způsob přípravy nového 4-/4-piperidyliden/-4>9-dihydrothieno/2,3~c/-2-benzothiepinu a jeho hydřogenmaleinátu